Home ›
Organizations ›
UNITED STATES PHARMACOPEIAL CONVENTION INC
UNITED STATES PHARMACOPEIAL CONVENTION INC
MD · Healthcare · EIN 131656692
33
Executives Disclosed
$357.7M
Annual Revenue
$788.7M
Total Assets
2.3:1
Internal Pay Ratio
UNITED STATES PHARMACOPEIAL CONVENTION INC has 33 executives with disclosed compensation. The highest-paid executive, Ronald T Piervincenzi (CHIEF EXECUTIVE OFFICER & EX-OFFICIO), received peak total compensation of $1,104,534. The sector average for Healthcare executives is $506K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Ronald T Piervincenzi | CHIEF EXECUTIVE OFFICER & EX-OFFICIO | $1.1M | $1.1M | 2016–2025 | 14.7x |
| Susan S De Mars | Frmr Chf. Legal Off. -end 1/19 | $836K | $318K | 2016–2020 | 11.2x |
| Scott P Henderson | SVP, Info & Svcs - end 10/2/19 | $798K | $798K | 2016–2020 | 10.6x |
| Jakob Venema To 625 | EVP & CHIEF SCIENCE OFFICER | $708K | $708K | 2025–2025 | 9.4x |
| Roger L Williams Phd | Former CEO | $684K | $684K | 2016–2016 | 9.1x |
| Jakob Venema | EVP & CHIEF SCIENCE OFFICER | $629K | $582K | 2016–2020 | 8.4x |
| Anthony P Lakavage | SECRETARY & SVP GLBL EA | $628K | $628K | 2017–2025 | 8.4x |
| John A Giannone To 824 | VP, COMPENDIAL OPERATIONS | $611K | $611K | 2025–2025 | 8.1x |
| Amanda D Cowley | SVP, LEGAL, STRATEGY & PEOPLE | $609K | $609K | 2020–2025 | 8.1x |
| Stanley D Burhans | CHIEF FINANCIAL OFFICER | $590K | $590K | 2017–2025 | 7.9x |
| Emily M Kaine | SVP, GBL HEALTH & MANUFACTURING SVCS | $580K | $580K | 2019–2025 | 7.7x |
| Richard C Wailes | EVP, COO through 7/07/2017 | $557K | $515K | 2016–2018 | 7.4x |
| Vijayaraghavan Srinivasan | Former EVP, Chief Science Ofcr | $551K | $551K | 2016–2017 | 7.4x |
| Venkat Surendra Nath Koduru | SVP REGIONS & PROGRAM OPS.(TO 6/25) | $528K | $528K | 2025–2025 | 7x |
| Debra J Perez | CHIEF EQUITY OFFICER | $519K | $519K | 2025–2025 | 6.9x |
| Michael S Levy | SVP, DIGITAL & INNOVATION | $487K | $487K | 2025–2025 | 6.5x |
| Bruk Alemayehu | SVP, GLOBAL LAB & TECHNICAL OPS | $483K | $483K | 2019–2025 | 6.4x |
| Fouad Atouf | SVP, SCI-GLOB BIO | $476K | $476K | 2025–2025 | 6.3x |
| Jennifer Devine | SVP, DOC STDS & COMP POLICY | $451K | $451K | 2020–2025 | 6x |
| Salah D Kivlighn | SVP, Global SMPO | $450K | $437K | 2017–2020 | 6x |
| Patrick H Lukulay | VP GPH Africa | $421K | $421K | 2018–2018 | 5.6x |
| Robert A Femia | SVP, Chemical Medicines | $415K | $397K | 2017–2018 | 5.5x |
| Hermes Van Der Lee | SVP, Global Lab Ops | $398K | $391K | 2016–2020 | 5.3x |
| Amanda Cowley | SVP, Strategy and BD | $385K | $393K | 2019–2019 | 5.1x |
| Christine Stunyo | SVP Global Human Resources | $376K | $376K | 2020–2020 | 5x |
| Ben A Firschein | Dir, GEA Rsrch & Analysis | $375K | $375K | 2020–2020 | 5x |
| Barbara B Hubert | VP, Global Strat Cust Dvlpmnt | $372K | $372K | 2016–2017 | 5x |
| Tina S Morris | SVP Compendial Science | $356K | $356K | 2016–2018 | 4.7x |
| Drew J Lutz | VP, Administrative Services | $348K | $348K | 2016–2017 | 4.6x |
| Samir Wahab | VP, RSL | $330K | $330K | 2016–2016 | 4.4x |
| Emily Kaine | SVP Global Public Health | $327K | $327K | 2018–2018 | 4.4x |
| Kelly S Willis | SVP, Global Public Health | $314K | $314K | 2016–2016 | 4.2x |
| Todd K Abraham Phd Mba | At-Large Trustee | $25K | $0 | 2018–2018 | 0.3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 13 | $487K | $922K | $6.3M |
| 2017 | 14 | $472K | $863K | $6.6M |
| 2018 | 14 | $476K | $913K | $6.2M |
| 2019 | 11 | $520K | $1.0M | $5.7M |
| 2020 | 13 | $489K | $944K | $6.4M |
| 2025 | 13 | $598K | $1.1M | $7.8M |
Email Alerts
Get notified about UNITED STATES PHARMACOPEIAL CONVENTION INC
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.